News
02-24-2011, 02:01 PM
The United Kingdom's regulatory board, has rejected Avastin (bevacizumab) for the treatment of patients suffering from metastatic breast cancer. There is simply not enough proof that the drug is truly beneficial in upping survival rates...
More... (http://mnt.to/f/3RB2)
More... (http://mnt.to/f/3RB2)